Exenatide and Factor VIIa (Recombinant)
Determining the interaction of Exenatide and Factor VIIa (Recombinant) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: exenatide
Brand name: Byetta Prefilled Pen, Bydureon, Bydureon BCise, Bydureon Pen, Bydureon Tray
Synonyms: n.a.
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: Coagulation factor VIIa (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Exenatide-Factor X (Human)
- Exenatide-Factor x human Intravenous
- Exenatide-Factor XIII
- Exenatide-Factor XIII (Human)
- Exenatide-Factor XIII A-Subunit (Recombinant)
- Exenatide-Factor XIII Concentrate (Human)
- Factor VIIa (Recombinant)-Exenatide extended release
- Factor VIIa (Recombinant)-Exenatide Extended-Release Injection (Bydureon BCise)
- Factor VIIa (Recombinant)-Exenatide Extended-Release Injection (Bydureon) (Pens)
- Factor VIIa (Recombinant)-Exenatide Extended-Release Injection (Bydureon) (Trays)
- Factor VIIa (Recombinant)-Exenatide Injection (Byetta)
- Factor VIIa (Recombinant)-Exenatide Subcutaneous